NOD/SCID/γcnull mouse:: an excellent recipient mouse model for engraftment of human cells

被引:1116
|
作者
Ito, M
Hiramatsu, H
Kobayashi, K
Suzue, K
Kawahata, M
Hioki, K
Ueyama, Y
Koyanagi, Y
Sugamura, K
Tsuji, K
Heike, T
Nakahata, T
机构
[1] Kyoto Univ, Dept Pediat, Cent Inst Expt Anim, Grad Sch Med, Kawasaki, Kanagawa 2160001, Japan
[2] Gunma Univ, Dept Parasitol, Sch Med, Gunma, Japan
[3] Tokai Univ, Dept Pathol, Sch Med, Tokai, Ibaraki, Japan
[4] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan
[5] Tohoku Univ, Grad Sch Med, Dept Immunol, Sendai, Miyagi 980, Japan
[6] Univ Tokyo, Div Cellular therapy, Adv Clin Res Ctr, Inst Med Sci, Tokyo, Japan
关键词
D O I
10.1182/blood-2001-12-0207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To establish a more appropriate animal recipient for xenotransplantation, NOD SCID/gamma(c)(null) mice double homozygous for the severe combined immunodeficiency (SCID) mutation and interieukin-2Rgamma (IL-2Rgamma) allelic mutation (gamma(c)(null)) were generated by 8 backcross matings of C57BL/6J-gamma(c)(null) mice and NOD/Shi-scid mice. When human CD34(+) cells from umbilical cord blood were transplanted into this strain, the engraftment rate in the peripheral circulation, spleen, and bone marrow were significantly higher than that in NOD/Shi-scid mice treated with anti-asialo GM1 antibody or in the beta2-microglobulindeficient NOD/LtSz-scid (NOD/SCID/beta2m(null)) mice, which were as completely defective in NK cell activity as NOD/SCID/gamma(c)(null) mice. The same high engraftment rate of human mature cells was observed in ascites when peripheral blood mononuclear cells were intraperitoneally transferred. In addition to the high engraftment rate, multilineage cell differentiation was also observed. Further, even 1 x 10(2) CD34(+) cells could grow and differentiate in this strain. These results suggest that NOD/SCIO/gamma(c)(null) mice were superior animal recipients for xenotransplantation and were especially valuable for human stem cell assay. To elucidate the mechanisms involved in the superior engraftment rate in NOD/SCID/gamma(c)(null) mice, cytolkine production of spleen cells stimulated with Listeria monocytogenes antigens was compared among these 3 strains of mice. The interferon-gamma production from dendritic cells from the NOD/SCID/gamma(c)(null) mouse spleen was significantly suppressed in comparison with findings in 2 other strains of mice. It is suggested that multiple immunological dysfunctions, including cytokine production capability, in addition to functional incompetence of T, B, and NK cells, may lead to the high engraftment levels of xenograft in NOD/SCID/gamma(c)(null) mice. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:3175 / 3182
页数:8
相关论文
共 50 条
  • [31] Prior cryopreservation of ex vivo-expanded cord blood cells is not detrimental to engraftment as measured in the NOD-SCID mouse model
    Rice, AM
    Wood, JA
    Milross, CG
    Collins, CJ
    Case, J
    Nordon, RE
    Vowels, MR
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (01): : 157 - 165
  • [32] Development and characterization of the nude/NOD/SCID mouse; a novel xenograft recipient used to study long term human hematopoietic and mesenchymal stem cell engraftment.
    Herrbrich, PE
    Meyerrose, TE
    Wang, XL
    Ge, SD
    Nolta, JA
    BLOOD, 2002, 100 (11) : 610A - 610A
  • [33] Determination of engraftment potential of human cord blood stem-progenitor cells as a function of donor cell dosage and gestational age in the NOD/SCID mouse model
    Ural, SH
    Sammel, MD
    Blakemore, KJ
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (03) : 990 - 994
  • [34] Clonality analysis of human myelodysplasia in SCID/NOD mouse.
    Turhan, AG
    Ribrag, V
    Novault, S
    Bonnet, ML
    Vantelon, JM
    Lefrere, F
    Varet, B
    Coulombel, L
    Pflumio, F
    Lemoine, FM
    BLOOD, 1997, 90 (10) : 4054 - 4054
  • [35] Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus Type 1 carriers in NOD/SCID/γcnull (NOG) mice
    Takajo, Ichiro
    Umeki, Kazumi
    Morishita, Kazuhiro
    Yamamoto, Ikuo
    Kubuki, Yoko
    Hatakeyama, Kinta
    Kataoka, Hiroaki
    Okayama, Akihiko
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (10) : 2205 - 2211
  • [36] Developing a Stable Diabetic Model for Human Islet Assessment in the NOD-scid Mouse
    Fraga, Daniel W.
    Gaber, A. Osama
    PUMPS AND PIPES: PROCEEDINGS OF THE ANNUAL CONFERENCE, 2011, : 193 - 202
  • [37] Pilot results on effects of human hMSC in an orthotopic SCID/NOD mouse model for cholangiocarcinoma
    Sen Gupta, A.
    Zhao, Y.
    Qin, J.
    Augsburger, D.
    Zhao, L.
    Camaj, P.
    Wang, Y.
    Nelson, P.
    Bruns, C. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 41 - 41
  • [38] Effects of human interleukin-18 and interleukin-12 treatment on human lymphocyte engraftment in NOD-scid mouse
    Senpuku, H
    Asano, T
    Matin, K
    Salam, MA
    Tsuha, Y
    Horibata, S
    Shimazu, Y
    Soeno, Y
    Aoba, T
    Sata, T
    Hanada, N
    Honda, M
    IMMUNOLOGY, 2002, 107 (02) : 232 - 242
  • [39] Establishment of the NOD/SCID mouse as a model for allogeneic GvHD.
    Koh, MBC
    Prentice, HG
    Corbo, M
    Cotter, FE
    Morgan, M
    Ravell, P
    Lowdell, MW
    BLOOD, 1999, 94 (10) : 330B - 330B
  • [40] Decreased homing efficiency of transduced human CD34+cells in the NOD/SCID mouse model.
    Hall, KM
    Horvath, TL
    Cornetta, K
    Abonour, R
    Srour, EF
    BLOOD, 2002, 100 (11) : 487B - 487B